Tacrolimus (FK506) is a macrolide immunosuppressive drug that is approved for the
prevention of allograft rejection. It is a standard component of immunosuppressive regimens …

Despite recent advances in microsurgical techniques and equipments, recovery of function
following repair of transected nerves often remains suboptimal. Contrary to traumatic injuries …

In adults, the outcome of nerve suture and nerve autograft remains generally unsatisfactory.
FK506 (tacrolimus), an immunosuppressant drug used in transplantation, has been reported …

Introduction Immunophilin ligands such as FK506 (FK) preserve erectile function (EF)
following cavernous nerve injury (CNI), although the precise mechanisms are unclear. We …

Immunophilins are a family of receptors for immunosuppressive drugs like cyclosporin A,
FK506, rapamycin and their non-immunosuppressive analogues, which are collectively …

Objectives: To assess the recovery of various muscle fibre types in the posterior
cricoarytenoid muscle after laryngeal reinnervation in the rat, and to determine the influence …

Tacrolimus, a widely used immunosuppressive drug for preventing graft rejection following
organ transplantation, was reported to develop neurotoxic side effects ranging from mild to …

Objectives: FK506 is an effective immunosuppressive drug for treating graft rejection in
transplants patients. However, the neuroregenerative effect of FK506 has been well …

A neurorrafia látero-terminal sem lesão do nervo doador representou grande avanço na
área de microcirurgia de nervos periféricos. O coto distal do nervo receptor é suturado na …